![Todd Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Carter
Technik-/Wissenschafts-/F&E-Leiter bei
VOYAGER THERAPEUTICS, INC.
Vermögen: 390 524 $ am 30.09.2026
Profil
Dr. Todd Carter is a Chief Scientific Officer at Voyager Therapeutics, Inc. Dr. Carter was previously employed as a Senior Director-Biology by BrainCells, Inc. He received his undergraduate degree from Texas A&M University and a doctorate degree from The Trustees of Columbia University in The City of New York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.02.2026 | 145.718 ( 0,24 % ) | 390 524 $ | 30.09.2026 |
Aktive Positionen von Todd Carter
| Unternehmen | Position | Beginn |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2018 |
Ehemalige bekannte Positionen von Todd Carter
| Unternehmen | Position | Ende |
|---|---|---|
BrainCells, Inc.
 BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Corporate Officer/Principal | - |
Ausbildung von Todd Carter
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
36
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
BrainCells, Inc.
BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
